Liang Bruce T, Stewart Douglas, Jacobson Kenneth A
Department of Medicine, Cardiovascular Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
Laboratory of Bioorganic Chemistry, National Institutes of Health, Bethesda, Maryland.
Drug Dev Res. 2001 Jan-Feb;52(1-2):366-378. doi: 10.1002/ddr.1136.
Adenosine is released in large amounts during myocardial ischemia and exerts potent cardioprotective effects in the heart. Although these observations on adenosine have been known for a long time, how adenosine acts to achieve its antiischemic effect remains incompletely understood. Recent advances in the chemistry and pharmacology of adenosine receptor ligands have provided important and novel information on the function of adenosine receptor subtypes in the cardiovascular system. The development of model systems for the cardiac actions of adenosine has yielded important insights into its mechanism of action and have begun to elucidate the sequence of signaling events from receptor activation to the actual exertion of its cardioprotective effect. The goal of the current article is to review recent advances on the cellular and molecular mechanisms that mediate the cardiac actions of adenosine and to show the cardioprotective effect of novel adenosine ligands.
腺苷在心肌缺血期间大量释放,并在心脏中发挥强大的心脏保护作用。尽管关于腺苷的这些观察结果早已为人所知,但腺苷如何发挥作用以实现其抗缺血作用仍未完全清楚。腺苷受体配体的化学和药理学方面的最新进展为腺苷受体亚型在心血管系统中的功能提供了重要的新信息。用于研究腺苷心脏作用的模型系统的发展,为其作用机制提供了重要见解,并已开始阐明从受体激活到实际发挥心脏保护作用的信号转导事件序列。本文的目的是综述介导腺苷心脏作用的细胞和分子机制的最新进展,并展示新型腺苷配体的心脏保护作用。